SANTORO ET AL.
BRIEF DEFINITIVE REPORT Veterans Administration Medical Center. MRL-lpr/lpr mice exhibit an accelerated and severe disease that has features of both SLE and RA (10) . Congenic MRL-+/+ mice, which lack the lpr gene but possess an autoimmune background (9, 10) , and C57BL/6-lpr/lpr mice, which possess the lpr gene on a nonautoimmune background, both develop an indolent type of lupus without an arthritic component . In Vitro Culture. 2 x 105 resident peritoneal M0 were dispensed in 96-well flat-bottomed plates (Costar, Cambridge, MA) in Eagle's Basal Medium (BME) (Gibco Laboratories Chagrin Falls, OH) plus 10% FCS and incubated at 37°C in a humidified atmosphere containing 5% C02 for 2 h. The cells were then washed and cultured for 2-24 h in BME with 0-150 wg/ml zymosan (Sigma Chemical Co., St. Louis, MO) . The supernatants were harvested and analyzed freshly for eicosanoid activity using enzyme immunoassays (11) with tracers purchased from AIA, Inc. (Aurora, CO) or dialyzed and examined for IL-1 activity, as previously described (12) . After adherence, 80-92% of cells were M0 as evaluated by nonspecific esterase staining. There were no significant differences in the percentage of M0 obtained from autoimmune vs. normal mice. In experiments using HPLC, 106 Mo were dispensed in 35-mm petri dishes in 2 ml BME and cultured for 2 h with 150 Rg/ml of zymosan at 37°C in 5% C02 .
HPLCAnalyses . Supernatants from freshly prepared samples were spiked with [3H]LTC4 (New England Nuclear, Boston, MA) (16,000 dpm, 120 pg) and [3H]LTD4 (15,000 dpm, 90 pg) to determine recovery and with PGB2 (Cayman Chemicals, Ann Arbor, MI) (500 ng) to provide a reference point for chromatographic analysis. HPLC analysis was performed using a liquid chromatograph (model 1090; Hewlett-Packard Co., Palo Alto, CA) . The gradient was run at a flowrate of 1 ml/min with the initial mobile phase being methanol/water/phosphoric acid (30:70 :0.02, vol/vol, pH 5.7, with ammonium hydroxide) for 6 min, followed by a linear gradient to 100% methanol over 44 min. The overall recovery of radioactivity was 81 ± 3% for [3H]LTC 4 and 74 t 3% for [3H]LTD4 in these samples .
Results
The profile of lipoxygenase metabolites produced by zymosan-stimulated peritoneal Mo from 16-wk-old autoimmune-prone and immunologically normal mice was initially investigated using reverse-phase HPLC and a gradient-mobile phase. The chromatogram obtained in zymosan-induced M0 from normal C57BL/6 +/+ mice ( Fig. 1 A) shows a peak that elutes with a retention time identical to that ofauthentic LTC4 ( Fig. 1, peak 1 ) and with a UV spectrum ( Fig. 1 , insert) characteristic of a leukotriene. Further analysis ofthis peak by enzyme immunoassay (EIA) ( Fig. 1 A histogram) confirmed the presence of LTC4. The second peak represents the 11-trans isomer of LTC4 ( Fig. 1 A) . PGB2, the internal standard (peak 3) elutes at 30.3 min . LTB4 was not detectable in the M0 supernatants . Similar profiles were observed in zymosan-activated Mo from autoimmune C57BL/6-lpr/lpr, MRL-+/+, and MRLlpr/lpr mice ( Fig. 1 , B-D, respectively) and from immunologically normal C3H/HeN mice (data not shown). Thus, Mm obtained from autoimmune and normal mice demonstrate qualitatively comparable lipoxygenase products on stimulation with zymosan, and in all cases the predominant leukotriene synthesized is LTC4.
The capacity of Mo from autoimmune-prone MRL mice and immunologically normal C3H/HeN mice of various ages to produce LTC4 was next investigated by directly measuring eicosanoid activity in the supernatants of zymosan-induced cultures using EIA. An age-associated increase in the ability of MRL-lpr/lpr Mo to produce LTC4 in response to zymosan was observed (Fig. 2) . In Mm from MRL-+/+ mice, no such enhancement was seen (Fig. 2) , and, in response to zymosan, M0 from the latter strain produced levels of LTC4 that were comparable with those from C3H/HeN mice (not shown). Zymosan stimulation of M0 from 6-and 20-wk-old autoimmune C57BL/6-1pr/lpr mice produced levels of LTC4 that were equivalent to those generated by Mo from age-matched control C57BL/6-+/+ and BALB/c mice (data not shown) . It remained possible that increased LTC4 production by Mo from MRL-1pr/1pr mice was the consequence of enhanced responsiveness to zymosan. This was investigated by optimally stimulating Mo (106/ml) from young (3-5 wk) and old (12-20 wk) MRL mice with zymosan (150 ug/ml) for 24 h, then testing the dialyzed In contrast to those from normal mice, a significant increase in spontaneous LTC4 production was observed in MW from MRL-lpr/lpr mice . A systematic survey of various autoimmune-prone strains revealed high spontaneous production of LTC4 to be a common feature of Mo from mice that manifested lupus-like illnesses (Fig . 3) . The augmented spontaneous LTC4 activity was found to increase further with age and was unrelated to either gender (not shown) or to MHC haplotype. Spontaneous LTC4 release was most marked in M0 from MRL-lpr/lpr mice (Fig . 3) . Measurements of PGE2 in MIA cultures from 4-(not shown) and 16- (Fig. 3) wk-old autoimmune mice for up to 24 h revealed no differences in the spontaneous release of prostanoids relative to normal mice .
Discussion
The results presented herein demonstrate that M0 from autoimmune-prone mice exhibit a novel aberration in arachidonic acid metabolism, producing levels of LTC4 that were up to 10 times greater than those from age-, sex-, and MHC-matched immunologically normal mice in the absence of deliberate addition of exogenous stimulants . Levels of LTC4 comparable with those spontaneously released by Mo from MRL-Ipr/lpr mice 8 wk of age or older (N10 -$ M) have been shown in vitro to (a) stimulate DNA synthesis in human epidermal keratinocytes (13) ; (b) augment the proliferation of human cultured fibroblasts (14) ; (c) induce the mitogenesis of human glomerular epithelial cells (15) ; and (d) replace the helper cell requirement for immune IFN production by murine T cells (7) . The age-associated increase in spontaneous LTC4 production was independent of sex and was shared by Mo from MHC disparate autoimmune mice with distinct patterns of disease. The data suggest that augmented spontaneous LTC4 release may be a common feature of mu- Spontaneous eicosanoid production by Mm from normal and autoimmune (+) murine strains at different ages . Supernatants from peritoneal M0 were cultured for 2 h or 24 h and assayed freshly for LTC4 (open bars) and PGE2 (hatched bars), respectively, by EIA. Results represent the mean t SE of 3-5 experiments . Spontaneous LTC4 release was significantly enhanced (p < 0.05) in M0 from 20-wk-old MRL-+/+ mice, 8-and ZO-wk-old MRL-1pr/lpr mice, and 10-wk-old C57BL/6-1pr/1pr mice relative to that from the respective control by a non-paired Student's t test. like illness of all strains tested, possessed the greatest capacity to produce LTC4 both spontaneously and in response to zymosan stimulation . The relationship between disease severity and augmented LTC4 production further indicates that the two phenomena may be pathogenetically linked . The mechanism by which spontaneous production of LTC4 may predispose to the development of autoimmune disease is a matter of speculation . However, by increasing vascular permeability and inducing the release of lysosomal enzymes (4, 5), LTC4 could contribute to the inflammatio .i and tissue destruction characteristically seen in lupus .
Summary
Eicosanoids have been implicated in the pathogenesis of autoimmune diseases .
In this study, peritoneal macrophages from autoimmune-prone mice were examined for their capacity to produce proinflammatory 5-lipoxygenase metabolites . The results indicate that enhanced production of leukotriene C4 is a common feature of murine autoimmunity and suggest further that aberrations in 5-lipoxygenase activity may play a role in the development of lupus .
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